Oil States Energy Services, LLC v. Greene's Energy Group, LLC -- Positions Taken in Selected Amicus Curiae Briefs

by McDonnell Boehnen Hulbert & Berghoff LLP

On November 27, 2017, the Supreme Court considered the question of whether the inter partes review process established by the U.S. Patent and Trademark Office in implementing portions of the Leahy-Smith America Invents Act or 2012 violates the Constitution by permitting a non-Article III court to deprive patentees of property rights, in Oil States Energy Services, LLC v. Greene's Energy Group, LLC.  The Federal Circuit ruled against patentee/Petitioner Oil States on the grounds that patents are public rights rather than private rights, and the Constitution does not require public rights to be adjudicated before Article III courts, pursuant inter alia to Stern v. Marshall, 564 US 462, 489-490 (2011).

The Court had before it the merits briefs from the parties as well as the Federal Government; the subject matter of these briefs have been discussed previously (see "Supreme Court Preview -- Oil States Energy Services, LLC v. Greene's Energy Group, LLC and Oil States Preview Take II -- Just What Did the Supreme Court Hold in McCormick Harvesting Machine v. Aultman?" -- as noted therein, there were "several" amicus briefs filed; specifically, 21 briefs were filed in support of Petitioner, 25 briefs in support of Respondent, and 12 briefs in support of nether party -- however, most of these briefs took a position that favored either Petitioner or Respondent).  The positions taken by these amici were in some ways as expected:  the brief from 39 Affected Patent Owners favored finding IPRs to be unconstitutional, while the brief from BSA: The Software Alliance urged the Court to uphold the constitutionality of IPRs.

It would be difficult, perhaps impossible, and certainly imprudent to post on all these amicus briefs.  Here we provide a synopsis of four briefs favoring the Petitioner, three favoring the Respondent, and three favoring neither party.


The Pharmaceutical Research and Manufacturers of America (PhRMA)

This brief argues that patents have long been held to be private not public rights, supporting this legal conclusion by "precedent, practice, common sense," and by analogy to other areas of the law.  The brief cites 35 U.S.C. § 261 as reciting that patents have "all the attributes of personal property" and analogizes the private property character of patents to Federal land grants and mining rights.  The brief, no doubt fully cognizant of the role the Supreme Court has played in identifying error by the Federal Circuit in almost every case where the Court has granted certiorari (even in those cases where it has affirmed the decision of its appellate inferior court) notes that it was the Federal Circuit's failure to recognize a patent as a private right rather than a public right that was the source of the error below.

The brief draws a bright line between the power of the USPTO over patents at the grant date:  Congress can impose whatever requirements it wants prior to grant but once the patent is granted it becomes private property that can only be rescinded by a court.  The Supreme Court's decision in Florida Prepaid Postsecondary Education Expense Board v. College Savings Bank (1999) is cited frequently in this brief for this proposition, but the argument also contains broad citation to 19th and 20th Century Supreme Court precedent on this point, as well as patent law treatises.  The brief also argues that acknowledging the status of a patent as a private property right is also consistent with a patentee's right to recompense from the government itself (albeit in the Court of Federal Claims) if the government infringes a patent.

The brief analogizes a patent's status as a private property right to copyright, which is expressly a private property right (because it stems from a common law right), recognizing that patents and copyrights are contained in the same section of Article I enumerating Congress's powers (and that the Court has just last term used such analogies itself in deciding patent law questions; see Impression Products v. Lexmark Int'l.).  The brief also illustrates the consequences that could be implicated by a contrary decision for farmers on land granted by the Federal government (reminiscent of Chief Justice Roberts' illustration in Lexmark using an automobile repair shop).

The brief also makes a distinction with ex parte and inter partes reexamination by noting that those were reexamination proceedings not frankly adversarial proceedings as IPRs were clearly intended by Congress to be.  The brief urges the Court to consider the history of the right and its status as a private property right and identifies yet another case (involving ex parte reexamination; Patlex Corp. v. Mossinghoff (Fed. Cir. 1985)) where the Federal Circuit erred in not recognizing that patents are private not public rights.

The Biotechnology Innovation Organization and the Association of University Technology Managers

The Biotechnology Innovation Organization (BIO) and the Association of University Technology Managers (AUTM) filed a joint brief in which they argued that patents are private rights, a conclusion which in their opinion was supported by ample precedent.  The brief also points out in particular that the government's position is contrary to precedent, on historical grounds, and as a practical matter how the U.S. patent system functions -- all arguments clearly intended to reduce the effectiveness the Solicitor General may have before the Court.  The brief also argues that the IPR regime is constitutionally flawed because the Court has permitted non-Article III adjudication only in limited circumstances.  In addition, amici argue that the Patent Trial and Appeal Board (PTAB) does not satisfy the Court's criteria under its precedent for Article I adjudication; specifically the brief argues that the Board operates "more broadly, and with less independence," than the Court requires; that the PTAB's procedures are not fair (essentially a due process argument); that the IPR regime has raised the possibility of "reverse trolling" (e.g., by "financial speculators" who use the threat of IPR institution to wrest financial compensation from patent holders); that how the PTAB operates is not fair and valid even when compared with the PTO's own procedures; and that these deleterious effects are even worse for patents (as is the one at issue) granted prior to passage of the AIA, because those patentees cannot be said to have acquiesced to the current situation.  The current IPR system is "imbalanced, expensive, and lacking in finality to the detriment of patent holders," according to the brief.  Moreover, the brief alleges that APJs lack independence from the (political appointee) Director and USPTO administration (and hence from the administration in charge of the Executive branch) and cites instances of "panel packing" (where the Director can and has changed the composition of a PTAB panel to increase (almost to certainty) how the Board will decide an IPR).  Exacerbating this opportunity for politically motivated mischief is the non-renewability of institution decisions by the (political appointee) Director.

The brief contains an interesting argument about securing a pre-existing right to property; in this view obtaining a patent doesn't create the right it but rather secures it.  Although not expressly argued, this raises an analogy to trade secret, where the undisclosed secret is plainly private property and both Federal and state laws protect said property.  The analogy regarding preexisting rights to an inventor's invention is bolstered in the brief with reference to the Court's decision in Board of Trustees of the Leland Stanford Junior University v. Roche Molecular Systems, Inc., wherein the Court held that ownership of an invention (as personal property) resided in the inventor, and Congress via the Bayh-Dole Act could not provide automatic assignment to universities by their researcher employees.

This brief contains some 19th Century precedential counterweight to historical arguments made in other briefs.  In particular, in this regard is McKeever v. U.S. from the Court of Claims, contrasting the American version of patenting with the British version (as a grant from the sovereign that the sovereign could revoke).  18th century writings from the Founders were cited for this principle.

The brief emphasized the Court's precedent limiting the scope of Article I adjudications, citing (as has other briefs) Crowell v Benson (1932), Thomas v Union Carbide Ag Prods. Co. (1985), and Commodities Future Trading Comm'n v Schor (1986).  Using this precedent, the brief argues that IPRs fall outside the scope of the instances where the Court has permitted Article I courts to adjudicate property rights, inter alia wherein they are not held by consent of the parties or limited to ministerial actions.

With regard to the issue of "reverse trolling," the brief with some irony argues that "[t]he end result is that patent owners are threatened with the very abuses that the AIA was enacted to remedy."

Finally, the brief includes arguments regarding the policy issues surrounding drug development costs.

AbbVie, Inc, Allergan, Inc., and Celgene Corp.

This brief provides further explication on public/private rights question, citing Murray's Lessee v Hoboken Land & Improvement Co. (1855), and Granfinanciera S.A. v Nordberg (1989), in support.  The historical development of the patent system is emphasized, acting as somewhat of a rebuttal to some of the law professsors' arguments in other briefs (see below).  The brief also takes an almost academic tone in explicating the 18th century meaning of the words in the Constitution and contemporaneous writings of Founders to support its arguments, and sets forth a  survey of 19th century case law in support of the notion that patents are a private property right.

Brief of 27 Law Professors

This brief, filed by Professor Adam Mossoff of the Antonin Scalia Law School at George Mason University on behalf of 26 of his colleagues, cites a recent case, Horne v Dept. of Agriculture (2015), for the proposition that the Court has treated patents as a private property right (supported of course by ample 19th century case law).  And in keeping with the theme that the Court is more than willing to correct error by the Federal Circuit, the brief reminds the Justices that "[t]o reverse the Federal Circuit in this case would not be the first time this Court has stopped the Federal Circuit in ignoring settled legal doctrine," citing (parsimoniously) Festo Corp. v. Shoketsu Kinzoku Kogyo Kabushiki (2002), and eBay v. MercExchange (2006).


72 Professors of Intellectual Property Law

This brief, submitted by Professor Mark Lemley from Stanford Law School, Professor Arti Rai from Duke Law School, and Professor Greg Reilly from IIT Chicago-Kent College of Law on behalf of 69 of their colleagues, argues that Article I courts are empowered to correct administrative errors in granting invalid patent claims.  Such correction is "integrally related" to the USPTO's administrative activity of granting patents, according to the professors, and that Congress has discretion to permit IPRs that do not threaten Article III prerogatives.  To the argument that private patent rights are put at risk without due process protections guaranteed by the Bill of Rights, the professors argue that the Federal Circuit provides the Article III check on Article I overreach (perhaps a risky argument before the Justices in view of recent trends in the Court engaging in a certain amount of correction of its own, with regard to the Federal Circuit).  In light of these arguments, the professors conclude that there is no Seventh Amendment violation.  Certain statements raise something of an eyebrow ("PTAB error correction . . . [is] targeted towards bad patents that district court litigation would not address" seems to overstate the issue; there is no reason given why a court would refuse to consider an invalidity contention), but as with many briefs in this case, this one cited Stern v. Marshall (2011), which in their view permits non-Article III courts to adjudicate claims arising from Federal statutory regimes ("when the right [at issue] is integrally related to particular government action").  The brief also characterizes IPRs as one of the conditions for patentability within Congress's power to enact.

The professors argue (as several of them have argued in their professional writings) that it is almost inevitable that the USPTO will grant patents erroneously, if only because of the number of applications received by the Office each year ("[s]uch high-throughput processing will inevitably produce error").  While undoubtedly true that the examining corps is busy, there is not only no pressure on the examiners to grant patents improvidently, those who understand how the Office operates know that an examiner gets equal "credit" for an allowance or an abandonment.  The brief also provides broad citation to the lack of Seventh Amendment right to jury trial in administrative proceedings, in an argument that these Justices are likely to gratefully receive as having greater affinity if not knowledge regarding administrative rather than patent law.

On a policy level the brief argues (echoing Justice Breyer's sentiments in this regard in his Mayo v. Prometheus decision, unlikely done accidentally) that patents involve a delicate balance between encouraging and stifling innovation.

Professors of Administrative Law, Federal Courts, and Intellectual Property Law

These professors (only nine on this brief) argue that the patent right is a sovereign grant of the right to exclude, not a common law property right, and thus IPRs provide no violation of Article III.  Like the brief from the Intellectual Property Lawyers Association of Chicago (see below), these professors draw a bright line between those patents that should fall within the ambit of IPRs (the America Inventors Protection Act of 1999, AIPA) (patents issuing from applications filed after passage of the AIPA) and those that should not (patents issuing from applications filed prior to enactment of the AIPA).

The brief asserts that IPRs were a way for the USPTO to adapt to the influx of patent applications in recent years, as well as "a choking multitude of issued patents" (which appropriately sets forth their biases).  These professors apparently believe that examiners are too overburdened to do their job properly ("the almost inevitable granting of invalid patent claims"), in common with arguments made in the 72 Law Professors brief.

These professors base their argument that patents are public rights falling within the scope of the exception to Article III adjudication requirement as set forth by the Supreme Court in Stern v. Marshall (2011).  And these professors trace the genesis of U.S. patents to the tradition of a letters patent as a grant from the sovereign that could be revoked by the sovereign.  As in other briefs, these professors make the comparison with land grants, saying that these land grants can be distinguished from patents because the land grant is a permanent right wherein the patent grant, which is of limited duration and for limited purpose.  Historically the brief reminds the Court that the British practice was the Privy Council to be able to revoke patents, and argues that in the U.S. practice of involving Article III courts in invalidating patents in then early days of the Republic stemmed from an overburdened Executive Branch rather than a doctrinal or philosophical determination that patents were private property rights that required an Article III court to decide whether the right could be taken from a patentee.

The brief makes the further argument that invalidating improvidently granted patents returns to the public rights to do what they could have had the right to do in the first place (ignoring the disclosure benefit the patentee gives the public in the first place).

Knowledge Ecology International

Andrew Goldman of KEI, writing for his organization, identifies their interest as social justice; in this vein the brief asserts the organization's belief that patents are public not private rights.  The brief argues that IPRs provide an "important corrective mechanism" and are only one way the USPTO implements its delegated responsibilities (mentioning Patent Term Extensions under 35 U.S.C. § 156 by illustration).  The brief identifies as "mistakes" the ~11% frequency of the USPTO issuing certificates of correction, and argue that the higher rate (about 2-fold higher, to around 25%) of these certificates in patents related to medical subject matter is significant.  (Unmentioned in the brief is the reality that certificates of correction are limited to ministerial corrections like typographical errors and errors that occur during printing the patent, whereas substantive corrections must be made by reissue.)

The brief also argues that patent thickets are a problem but illustrates this with aviation (~1910's) and, of course, the Court's Myriad decision (arguing that this decision resulted in increased innovation, but showing no evidence of anything other than copying).  The brief's argument in this regard is more cogent making the case for the potential for patent thickets to arise over CRISPR and CAR-T technology but shows no evidence and makes no persuasive argument either that there is a patent thicket or that IPRs can solve this problem should it arise.  Indeed, this portion of the brief is a good example of the rhetorical error of begging the question, because there is no indication that these patents have or will be challenged under the IPR regime.

The brief also argues that patents are only one factor for innovation and other incentives should be considered and promoted, and advocates that patents should be "delinked" from innovation by relying on other means for providing the patent incentive.  These other incentives include the Orphan Drug Act, the Hatch-Waxman Act, and the Biologics Price Control and Innovation Act (BPCIA) as examples of these alternative forms of incentivizing innovation.

Briefs in support of neither party

Association for Accessible Medicines (previously known as the Generic Pharmaceutical Association)

This brief argues that patents are part of a federal regulatory scheme (which is the standard under Stern v Marshall for permitting Article I courts to adjudicate property rights) and that IPRs are "essential" (another Stern requirement) for the "limited regulatory objective" of eliminating invalid patents.  As in other briefs, this one argues that the overburdened USPTO results in the grant of invalid patents (saying this is "inevitable) but provides neither evidence nor argument that said "invalid" patents arise at any particular frequency.  The brief argues that the existence of interferences and ex parte and inter partes reexamination is sufficient to validate Congress's actions in creating the PTAB and the IPR regime, and makes the further argument that IPRs are necessary because invalid patents block generic and biosimilar copies of patented medicines, using the example of ANDA litigation over the small molecule drug omeprazole for "delaying" generic entry into the market by three years.

Intellectual Property Lawyers Association of Chicago (IPLAC)

IPLAC, in a brief by its President Paul Kitch, argues that the Supreme Court should draw a distinction between patents granted on applications filed prior to enactment of the AIA and those filed after AIA passage.  The brief argues that the Court can hold that IPRs are constitutional for post-AIA granted patents because Congress has the right to provide for IPRs under its Article I powers and applicants have consented to the IPR regime by filing applications knowing that they would be subject to this means of invalidation.  This argument would redefine the process of getting a patent to include IPRs, and thus for grant to be subject to revocation at any time during a patent's term (which was not understood at the time an applicant filed a patent for pre-AIA patents).  The brief argues that this would be within the scope of Congressional rights, perhaps better stated as being within the proper scope of Congress's powers under the Constitution.

Shire Pharmaceuticals  LLC

Shire's brief, submitted by its Chief Patent Counsel James Harrington, is nominally filed on behalf of neither party.  However, it should be kept in mind that Shire was the target of activities by non-practicing financial entities who filed an IPR petition against patents protecting an important Shire product, wherein said financial entities were cognizant of the short term advantages that could accrue to an entity aware beforehand that an IPR petition would be filed.  Understandably, both the tenor and the substance of Shire's brief reflect these experiences.

The brief begins by making the policy argument that patent rights are important for new drug research and development, particularly for drugs for rare diseases that is the company's focus.  The brief argues that patent rights are a "vested private property right" (VPPR) and can only be taken away by the legitimate actions of an Article III court.  IPR proceedings "unduly harm" innovator biotechnology companies when it takes such VPPRs "in a forum statutorily designed to be subject to political influence," according to the brief, and in view of the importance of patent rights as VPPRs, political influence permitted by the IPR regime "unconstitutionally destabilizes innovator patent rights."  The brief gives little credence to the argument that judicial review of Final Written Decisions from the PTAB provide an avenue for rectifying these structural liabilities, due to "very deferential standards of review."

The brief further argues that IPRs are subject to undue "political influence" as being designed to implement executive branch policy goals, and that VPPRs can be and are subject to these policy decisions without due process, being subject to "shifting political winds" as administrations change.  The brief argues that not only does the Director (a political appointee) decide which IPRs to institute and choose the judges, but can and does add to the panel to achieve uniformity by "fluid, case-based interpretations of its regulations."

The brief cites plentiful Supreme Court precedent to the effect that patent rights are private property vested in the patentee upon grant, and makes an explicit analogy with land grants and how the Court has adjudicated these rights.  While many of the arguments hint at the possibility for corruption in the process, the brief is careful to note that they are not arguing corruption but rather the proper allocation of power between the three branches of government.  The brief supports this argument with regard to the Federal Circuit having voiced concerns regarding this potential for due process violations.

The brief argues that the PTAB is capable of and actually uses a flexible standard for making law that is the opposite of stare decisis, using statistics that of 1,577 Final Written Decisions promulgated by the PTAB, only 37 of these decisions are precedential and only 11 of these are in IPR proceedings.  In addition the brief argues that the procedural limitations regarding discovery, cross-examination, and claim amendments prevent patentees from having their patent rights properly adjudicated.

Regarding appellate review, the brief cited Administrative Procedures Act § 706 that limits overturning PTAB decisions to those that are "arbitrary, capricious, and abuse of discretion or otherwise not in accordance with law" and reviews factual determinations for substantial evidence.  As a result, the Federal Circuit issued summary affirmances 49.11% of the time; affirmed on every issue 75.62% of the time, and reversed or vacated on every issue 9.95% of the time.

The brief also cites instances where the PTAB came to a different conclusion than the Federal Circuit regarding validity, and as a result, the agency decision then trumped a decision by an Article III court, and the portion of the statute that makes the Director's decision whether or not to institute not appealable, and can continue the IPR even when the parties have settled, all as evidence that the IPR regime exceeds Constitutional limits on Congressional power.

The brief also points out that the Director has the ability to intervene in an appeal of an IPR decision, which makes the USPTO an interested party, and that the possibility for political influence on PTAB decisions arises in part because Administrative Patent Judges (APJs) are not the USPTO equivalent of Administrative Law Judges (ALJs) because ALJs are protected by statute in pay and job security and are permitted ex parte communication with USPTO officials about cases before them.  According to the brief, by design in the statute, the PTAB lacks procedural safeguards to protect patent property right owners from aforesaid political influence.  For the reasons set forth above, safeguards in other Article I court settings deemed "important" by the Supreme Court are absent in the PTAB (wherein the PTAB is under the political influence of the Executive Branch).

DISCLAIMER: Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on particular situations.

© McDonnell Boehnen Hulbert & Berghoff LLP | Attorney Advertising

Written by:

McDonnell Boehnen Hulbert & Berghoff LLP

McDonnell Boehnen Hulbert & Berghoff LLP on:

Readers' Choice 2017
Reporters on Deadline

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
Custom Email Digest
- hide

JD Supra Privacy Policy

Updated: May 25, 2018:

JD Supra is a legal publishing service that connects experts and their content with broader audiences of professionals, journalists and associations.

This Privacy Policy describes how JD Supra, LLC ("JD Supra" or "we," "us," or "our") collects, uses and shares personal data collected from visitors to our website (located at www.jdsupra.com) (our "Website") who view only publicly-available content as well as subscribers to our services (such as our email digests or author tools)(our "Services"). By using our Website and registering for one of our Services, you are agreeing to the terms of this Privacy Policy.

Please note that if you subscribe to one of our Services, you can make choices about how we collect, use and share your information through our Privacy Center under the "My Account" dashboard (available if you are logged into your JD Supra account).

Collection of Information

Registration Information. When you register with JD Supra for our Website and Services, either as an author or as a subscriber, you will be asked to provide identifying information to create your JD Supra account ("Registration Data"), such as your:

  • Email
  • First Name
  • Last Name
  • Company Name
  • Company Industry
  • Title
  • Country

Other Information: We also collect other information you may voluntarily provide. This may include content you provide for publication. We may also receive your communications with others through our Website and Services (such as contacting an author through our Website) or communications directly with us (such as through email, feedback or other forms or social media). If you are a subscribed user, we will also collect your user preferences, such as the types of articles you would like to read.

Information from third parties (such as, from your employer or LinkedIn): We may also receive information about you from third party sources. For example, your employer may provide your information to us, such as in connection with an article submitted by your employer for publication. If you choose to use LinkedIn to subscribe to our Website and Services, we also collect information related to your LinkedIn account and profile.

Your interactions with our Website and Services: As is true of most websites, we gather certain information automatically. This information includes IP addresses, browser type, Internet service provider (ISP), referring/exit pages, operating system, date/time stamp and clickstream data. We use this information to analyze trends, to administer the Website and our Services, to improve the content and performance of our Website and Services, and to track users' movements around the site. We may also link this automatically-collected data to personal information, for example, to inform authors about who has read their articles. Some of this data is collected through information sent by your web browser. We also use cookies and other tracking technologies to collect this information. To learn more about cookies and other tracking technologies that JD Supra may use on our Website and Services please see our "Cookies Guide" page.

How do we use this information?

We use the information and data we collect principally in order to provide our Website and Services. More specifically, we may use your personal information to:

  • Operate our Website and Services and publish content;
  • Distribute content to you in accordance with your preferences as well as to provide other notifications to you (for example, updates about our policies and terms);
  • Measure readership and usage of the Website and Services;
  • Communicate with you regarding your questions and requests;
  • Authenticate users and to provide for the safety and security of our Website and Services;
  • Conduct research and similar activities to improve our Website and Services; and
  • Comply with our legal and regulatory responsibilities and to enforce our rights.

How is your information shared?

  • Content and other public information (such as an author profile) is shared on our Website and Services, including via email digests and social media feeds, and is accessible to the general public.
  • If you choose to use our Website and Services to communicate directly with a company or individual, such communication may be shared accordingly.
  • Readership information is provided to publishing law firms and authors of content to give them insight into their readership and to help them to improve their content.
  • Our Website may offer you the opportunity to share information through our Website, such as through Facebook's "Like" or Twitter's "Tweet" button. We offer this functionality to help generate interest in our Website and content and to permit you to recommend content to your contacts. You should be aware that sharing through such functionality may result in information being collected by the applicable social media network and possibly being made publicly available (for example, through a search engine). Any such information collection would be subject to such third party social media network's privacy policy.
  • Your information may also be shared to parties who support our business, such as professional advisors as well as web-hosting providers, analytics providers and other information technology providers.
  • Any court, governmental authority, law enforcement agency or other third party where we believe disclosure is necessary to comply with a legal or regulatory obligation, or otherwise to protect our rights, the rights of any third party or individuals' personal safety, or to detect, prevent, or otherwise address fraud, security or safety issues.
  • To our affiliated entities and in connection with the sale, assignment or other transfer of our company or our business.

How We Protect Your Information

JD Supra takes reasonable and appropriate precautions to insure that user information is protected from loss, misuse and unauthorized access, disclosure, alteration and destruction. We restrict access to user information to those individuals who reasonably need access to perform their job functions, such as our third party email service, customer service personnel and technical staff. You should keep in mind that no Internet transmission is ever 100% secure or error-free. Where you use log-in credentials (usernames, passwords) on our Website, please remember that it is your responsibility to safeguard them. If you believe that your log-in credentials have been compromised, please contact us at privacy@jdsupra.com.

Children's Information

Our Website and Services are not directed at children under the age of 16 and we do not knowingly collect personal information from children under the age of 16 through our Website and/or Services. If you have reason to believe that a child under the age of 16 has provided personal information to us, please contact us, and we will endeavor to delete that information from our databases.

Links to Other Websites

Our Website and Services may contain links to other websites. The operators of such other websites may collect information about you, including through cookies or other technologies. If you are using our Website or Services and click a link to another site, you will leave our Website and this Policy will not apply to your use of and activity on those other sites. We encourage you to read the legal notices posted on those sites, including their privacy policies. We are not responsible for the data collection and use practices of such other sites. This Policy applies solely to the information collected in connection with your use of our Website and Services and does not apply to any practices conducted offline or in connection with any other websites.

Information for EU and Swiss Residents

JD Supra's principal place of business is in the United States. By subscribing to our website, you expressly consent to your information being processed in the United States.

  • Our Legal Basis for Processing: Generally, we rely on our legitimate interests in order to process your personal information. For example, we rely on this legal ground if we use your personal information to manage your Registration Data and administer our relationship with you; to deliver our Website and Services; understand and improve our Website and Services; report reader analytics to our authors; to personalize your experience on our Website and Services; and where necessary to protect or defend our or another's rights or property, or to detect, prevent, or otherwise address fraud, security, safety or privacy issues. Please see Article 6(1)(f) of the E.U. General Data Protection Regulation ("GDPR") In addition, there may be other situations where other grounds for processing may exist, such as where processing is a result of legal requirements (GDPR Article 6(1)(c)) or for reasons of public interest (GDPR Article 6(1)(e)). Please see the "Your Rights" section of this Privacy Policy immediately below for more information about how you may request that we limit or refrain from processing your personal information.
  • Your Rights
    • Right of Access/Portability: You can ask to review details about the information we hold about you and how that information has been used and disclosed. Note that we may request to verify your identification before fulfilling your request. You can also request that your personal information is provided to you in a commonly used electronic format so that you can share it with other organizations.
    • Right to Correct Information: You may ask that we make corrections to any information we hold, if you believe such correction to be necessary.
    • Right to Restrict Our Processing or Erasure of Information: You also have the right in certain circumstances to ask us to restrict processing of your personal information or to erase your personal information. Where you have consented to our use of your personal information, you can withdraw your consent at any time.

You can make a request to exercise any of these rights by emailing us at privacy@jdsupra.com or by writing to us at:

Privacy Officer
JD Supra, LLC
10 Liberty Ship Way, Suite 300
Sausalito, California 94965

You can also manage your profile and subscriptions through our Privacy Center under the "My Account" dashboard.

We will make all practical efforts to respect your wishes. There may be times, however, where we are not able to fulfill your request, for example, if applicable law prohibits our compliance. Please note that JD Supra does not use "automatic decision making" or "profiling" as those terms are defined in the GDPR.

  • Timeframe for retaining your personal information: We will retain your personal information in a form that identifies you only for as long as it serves the purpose(s) for which it was initially collected as stated in this Privacy Policy, or subsequently authorized. We may continue processing your personal information for longer periods, but only for the time and to the extent such processing reasonably serves the purposes of archiving in the public interest, journalism, literature and art, scientific or historical research and statistical analysis, and subject to the protection of this Privacy Policy. For example, if you are an author, your personal information may continue to be published in connection with your article indefinitely. When we have no ongoing legitimate business need to process your personal information, we will either delete or anonymize it, or, if this is not possible (for example, because your personal information has been stored in backup archives), then we will securely store your personal information and isolate it from any further processing until deletion is possible.
  • Onward Transfer to Third Parties: As noted in the "How We Share Your Data" Section above, JD Supra may share your information with third parties. When JD Supra discloses your personal information to third parties, we have ensured that such third parties have either certified under the EU-U.S. or Swiss Privacy Shield Framework and will process all personal data received from EU member states/Switzerland in reliance on the applicable Privacy Shield Framework or that they have been subjected to strict contractual provisions in their contract with us to guarantee an adequate level of data protection for your data.

California Privacy Rights

Pursuant to Section 1798.83 of the California Civil Code, our customers who are California residents have the right to request certain information regarding our disclosure of personal information to third parties for their direct marketing purposes.

You can make a request for this information by emailing us at privacy@jdsupra.com or by writing to us at:

Privacy Officer
JD Supra, LLC
10 Liberty Ship Way, Suite 300
Sausalito, California 94965

Some browsers have incorporated a Do Not Track (DNT) feature. These features, when turned on, send a signal that you prefer that the website you are visiting not collect and use data regarding your online searching and browsing activities. As there is not yet a common understanding on how to interpret the DNT signal, we currently do not respond to DNT signals on our site.

Access/Correct/Update/Delete Personal Information

For non-EU/Swiss residents, if you would like to know what personal information we have about you, you can send an e-mail to privacy@jdsupra.com. We will be in contact with you (by mail or otherwise) to verify your identity and provide you the information you request. We will respond within 30 days to your request for access to your personal information. In some cases, we may not be able to remove your personal information, in which case we will let you know if we are unable to do so and why. If you would like to correct or update your personal information, you can manage your profile and subscriptions through our Privacy Center under the "My Account" dashboard. If you would like to delete your account or remove your information from our Website and Services, send an e-mail to privacy@jdsupra.com.

Changes in Our Privacy Policy

We reserve the right to change this Privacy Policy at any time. Please refer to the date at the top of this page to determine when this Policy was last revised. Any changes to our Privacy Policy will become effective upon posting of the revised policy on the Website. By continuing to use our Website and Services following such changes, you will be deemed to have agreed to such changes.

Contacting JD Supra

If you have any questions about this Privacy Policy, the practices of this site, your dealings with our Website or Services, or if you would like to change any of the information you have provided to us, please contact us at: privacy@jdsupra.com.

JD Supra Cookie Guide

As with many websites, JD Supra's website (located at www.jdsupra.com) (our "Website") and our services (such as our email article digests)(our "Services") use a standard technology called a "cookie" and other similar technologies (such as, pixels and web beacons), which are small data files that are transferred to your computer when you use our Website and Services. These technologies automatically identify your browser whenever you interact with our Website and Services.

How We Use Cookies and Other Tracking Technologies

We use cookies and other tracking technologies to:

  1. Improve the user experience on our Website and Services;
  2. Store the authorization token that users receive when they login to the private areas of our Website. This token is specific to a user's login session and requires a valid username and password to obtain. It is required to access the user's profile information, subscriptions, and analytics;
  3. Track anonymous site usage; and
  4. Permit connectivity with social media networks to permit content sharing.

There are different types of cookies and other technologies used our Website, notably:

  • "Session cookies" - These cookies only last as long as your online session, and disappear from your computer or device when you close your browser (like Internet Explorer, Google Chrome or Safari).
  • "Persistent cookies" - These cookies stay on your computer or device after your browser has been closed and last for a time specified in the cookie. We use persistent cookies when we need to know who you are for more than one browsing session. For example, we use them to remember your preferences for the next time you visit.
  • "Web Beacons/Pixels" - Some of our web pages and emails may also contain small electronic images known as web beacons, clear GIFs or single-pixel GIFs. These images are placed on a web page or email and typically work in conjunction with cookies to collect data. We use these images to identify our users and user behavior, such as counting the number of users who have visited a web page or acted upon one of our email digests.

JD Supra Cookies. We place our own cookies on your computer to track certain information about you while you are using our Website and Services. For example, we place a session cookie on your computer each time you visit our Website. We use these cookies to allow you to log-in to your subscriber account. In addition, through these cookies we are able to collect information about how you use the Website, including what browser you may be using, your IP address, and the URL address you came from upon visiting our Website and the URL you next visit (even if those URLs are not on our Website). We also utilize email web beacons to monitor whether our emails are being delivered and read. We also use these tools to help deliver reader analytics to our authors to give them insight into their readership and help them to improve their content, so that it is most useful for our users.

Analytics/Performance Cookies. JD Supra also uses the following analytic tools to help us analyze the performance of our Website and Services as well as how visitors use our Website and Services:

  • HubSpot - For more information about HubSpot cookies, please visit legal.hubspot.com/privacy-policy.
  • New Relic - For more information on New Relic cookies, please visit www.newrelic.com/privacy.
  • Google Analytics - For more information on Google Analytics cookies, visit www.google.com/policies. To opt-out of being tracked by Google Analytics across all websites visit http://tools.google.com/dlpage/gaoptout. This will allow you to download and install a Google Analytics cookie-free web browser.

Facebook, Twitter and other Social Network Cookies. Our content pages allow you to share content appearing on our Website and Services to your social media accounts through the "Like," "Tweet," or similar buttons displayed on such pages. To accomplish this Service, we embed code that such third party social networks provide and that we do not control. These buttons know that you are logged in to your social network account and therefore such social networks could also know that you are viewing the JD Supra Website.

Controlling and Deleting Cookies

If you would like to change how a browser uses cookies, including blocking or deleting cookies from the JD Supra Website and Services you can do so by changing the settings in your web browser. To control cookies, most browsers allow you to either accept or reject all cookies, only accept certain types of cookies, or prompt you every time a site wishes to save a cookie. It's also easy to delete cookies that are already saved on your device by a browser.

The processes for controlling and deleting cookies vary depending on which browser you use. To find out how to do so with a particular browser, you can use your browser's "Help" function or alternatively, you can visit http://www.aboutcookies.org which explains, step-by-step, how to control and delete cookies in most browsers.

Updates to This Policy

We may update this cookie policy and our Privacy Policy from time-to-time, particularly as technology changes. You can always check this page for the latest version. We may also notify you of changes to our privacy policy by email.

Contacting JD Supra

If you have any questions about how we use cookies and other tracking technologies, please contact us at: privacy@jdsupra.com.

- hide

This website uses cookies to improve user experience, track anonymous site usage, store authorization tokens and permit sharing on social media networks. By continuing to browse this website you accept the use of cookies. Click here to read more about how we use cookies.